Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Nivolumab and Ablation For Patients With Advanced Non-Small Cell Lung Cancer Progressing After at Least One Prior Therapy For Metastatic Disease: A Brown University Oncology Research Group Phase II Study

NCT02469701 is registered in ClinicalTrials.gov with howard safran as lead sponsor.

NCT NCT02469701
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02469701 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Nivolumab and Ablation For Patients With Advanced Non-Small Cell Lung Cancer Progressing After at Least One Prior Therapy For Metastatic Disease: A Brown University Oncology Research Group Phase II Study
Lead sponsor
howard safran
Phase
Phase 2
Overall status
Terminated
Start date
February 29, 2016
Completion date
March 31, 2018
Enrollment
10 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer, metastatic lung cancer, non-small cell lung cancer, nsclc